Skip to main content
Erschienen in: Rheumatology International 1/2005

01.11.2005 | Original Article

HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus

verfasst von: Antoni Hrycek, Urszula Siekiera, Paweł Cieślik, Witold Szkróbka

Erschienen in: Rheumatology International | Ausgabe 1/2005

Einloggen, um Zugang zu erhalten

Abstract

Objective

The objective of this study was to evaluate the genetic profiles of selected cytokines (transforming growth factor beta 1, tumor necrosis factor alpha, interleukin-6, interferon gamma, and interleukin-10) in systemic lupus erythematosus and the contributions of human leukocyte antigen (HLA)-DRB1 and -DQB1 alleles to susceptibility for this disease.

Patients and methods

The study was carried out in 24 SLE patients and 36 healthy controls (from Upper Silesia) using polymerase chain reaction methods. All persons were of Caucasoid origin. Standard association analysis was used to compare the HLA alleles and frequency of cytokine gene polymorphisms between these groups.

Results

Only the frequency of HLA-DRB1*07 allele was higher in SLE patients than controls (odds ratio 2.92, 95% confidence interval 1.16–7.33), but the difference did not reach statistical significance when Bonferroni’s adjustment procedure was performed. No other significant associations were noted between class II alleles (DR1-DR6, DR8-DR10, DQ1-DQ4) and SLE. The frequency of the interleukin-6 GG and GC genotypes was significantly higher in SLE patients than in controls, and a significantly higher percentage of the G vs C alleles between patients and controls was revealed (odds ratio 2.53, 95% confidence interval 1.37–4.65, chi-squared test 8.16, P<0.05). The most significant association of increased frequency of the G allele with SLE was more commonly noted in HLA-DRB1*07-positive patients (odds ratio 10.29, 95% confidence interval 5.34–19.83, P<0.001). These data indicate that this combination could contribute toward determining the susceptibility to SLE, but its possible significance will require confirmation by further studies.
Literatur
1.
Zurück zum Zitat Lindqvist AKB, Alarcón-Riquelme ME (1999) The genetics of systemic lupus erythematosus. Scand J Immunol 50:562–571CrossRefPubMed Lindqvist AKB, Alarcón-Riquelme ME (1999) The genetics of systemic lupus erythematosus. Scand J Immunol 50:562–571CrossRefPubMed
2.
Zurück zum Zitat Alcocer-Varela J, Iglesias A, Llorente L, Alarcon-Segovia D (1985) Effects of L-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa. Arthritis Rheum 28:52–57PubMed Alcocer-Varela J, Iglesias A, Llorente L, Alarcon-Segovia D (1985) Effects of L-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa. Arthritis Rheum 28:52–57PubMed
3.
Zurück zum Zitat Tsao BP (2002) An update on genetic studies of systemic lupus erythematosus. Curr Rheumatol Rep 4:359–367PubMed Tsao BP (2002) An update on genetic studies of systemic lupus erythematosus. Curr Rheumatol Rep 4:359–367PubMed
4.
Zurück zum Zitat Tan FK, Arnett FC (1998) The genetics of lupus. Curr Opin Rheumatol 7:399–408 Tan FK, Arnett FC (1998) The genetics of lupus. Curr Opin Rheumatol 7:399–408
5.
Zurück zum Zitat Tsao BP (1998) Genetic susceptibility to lupus nephritis. Lupus 8:585–590CrossRef Tsao BP (1998) Genetic susceptibility to lupus nephritis. Lupus 8:585–590CrossRef
6.
Zurück zum Zitat Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397–408CrossRefPubMed Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397–408CrossRefPubMed
7.
Zurück zum Zitat Davies EJ, Steers G, Ollier WER, Grennan DM, Cooper RG, Hay EM, Hillarby MC (1995) Relative contributions of HLA-DQA and complement C4A loci in determining susceptibility to systemic lupus erythematosus. Br J Rheumatol 34:221–225PubMed Davies EJ, Steers G, Ollier WER, Grennan DM, Cooper RG, Hay EM, Hillarby MC (1995) Relative contributions of HLA-DQA and complement C4A loci in determining susceptibility to systemic lupus erythematosus. Br J Rheumatol 34:221–225PubMed
8.
Zurück zum Zitat Sullivan KE (2000) Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 26:229–256PubMed Sullivan KE (2000) Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 26:229–256PubMed
9.
Zurück zum Zitat Gladman DD, Urowitz MB, Darlington GA (1999) Disease expression and class II HLA antigens in systemic lupus erythematosus. Lupus 8:466–470CrossRefPubMed Gladman DD, Urowitz MB, Darlington GA (1999) Disease expression and class II HLA antigens in systemic lupus erythematosus. Lupus 8:466–470CrossRefPubMed
10.
Zurück zum Zitat Schotte H, Willeke P, Rust S, Assmann G, Domschke W, Gaubitz M, Schluter B (2003) The transforming growth factor-beta1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 12:86–92CrossRefPubMed Schotte H, Willeke P, Rust S, Assmann G, Domschke W, Gaubitz M, Schluter B (2003) The transforming growth factor-beta1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 12:86–92CrossRefPubMed
11.
Zurück zum Zitat Walker SE, McMurray RW, Houri JM, Allen SH, Keisler D, Sharp GC, Schlechte JA (1998) Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann N Y Acad Sci 840:762–772PubMed Walker SE, McMurray RW, Houri JM, Allen SH, Keisler D, Sharp GC, Schlechte JA (1998) Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann N Y Acad Sci 840:762–772PubMed
12.
Zurück zum Zitat Hrycek A, Cieślik P, Tustanowski J, Nowak S, Jedynak P (2001) Selected serum cytokines in systemic lupus erythematosus treated with quinagolide. Lupus 10:424–430CrossRefPubMed Hrycek A, Cieślik P, Tustanowski J, Nowak S, Jedynak P (2001) Selected serum cytokines in systemic lupus erythematosus treated with quinagolide. Lupus 10:424–430CrossRefPubMed
13.
Zurück zum Zitat Wilder RI (1998) Hormones, pregnancy and autoimmune diseases. Ann N Y Acad Sci 840:45–50PubMed Wilder RI (1998) Hormones, pregnancy and autoimmune diseases. Ann N Y Acad Sci 840:45–50PubMed
14.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed
15.
Zurück zum Zitat Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMed Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMed
16.
Zurück zum Zitat Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 h: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225–235PubMed Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 h: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225–235PubMed
17.
Zurück zum Zitat Gardner MJ, Altman DG (1989) Statistics with confidence. British Medical Journal Books, London Gardner MJ, Altman DG (1989) Statistics with confidence. British Medical Journal Books, London
18.
Zurück zum Zitat Hochberg Y, Tamhane AC (1987) Multiple comparison procedures. Wiley and Sons, New York Hochberg Y, Tamhane AC (1987) Multiple comparison procedures. Wiley and Sons, New York
19.
Zurück zum Zitat Millard TP, Kondeatis E, Vaughan RW, Lewis CM, Khamashta MA, Hughes GRV, Hawk JLM, McGregor JM (2001) Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus. Lupus 10:473–479CrossRefPubMed Millard TP, Kondeatis E, Vaughan RW, Lewis CM, Khamashta MA, Hughes GRV, Hawk JLM, McGregor JM (2001) Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus. Lupus 10:473–479CrossRefPubMed
20.
Zurück zum Zitat Schur PH (1995) Genetics of systemic lupus erythematosus. Lupus 4:425–437PubMed Schur PH (1995) Genetics of systemic lupus erythematosus. Lupus 4:425–437PubMed
21.
Zurück zum Zitat Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC (1999) Serum IL-6, TNF alpha, p 75 sr TNF alpha, sr IL-2 alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 18:17–22 Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC (1999) Serum IL-6, TNF alpha, p 75 sr TNF alpha, sr IL-2 alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 18:17–22
22.
Zurück zum Zitat Linker-Israeli M, Deanes RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinkenberg JR ( 1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147:117–123PubMed Linker-Israeli M, Deanes RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinkenberg JR ( 1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147:117–123PubMed
23.
Zurück zum Zitat Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza L R (1998) Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol 17:110–114 Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza L R (1998) Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol 17:110–114
24.
Zurück zum Zitat Park YB, Lee SK, Kim DS, Lee J, Lee CH, Song CH (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp. Rheumatol 16:283–288 Park YB, Lee SK, Kim DS, Lee J, Lee CH, Song CH (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp. Rheumatol 16:283–288
25.
Zurück zum Zitat Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WER, Hutchinson IV (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J. Rheumatol 24:2314–2317 Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WER, Hutchinson IV (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J. Rheumatol 24:2314–2317
26.
Zurück zum Zitat Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Mattey DL, Amoli MM, Thomson W, Ollier WER ( 2002) IL-6 promoter polymorphism at position-174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. Clin Exp Rheumatol 20:179–184 Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Mattey DL, Amoli MM, Thomson W, Ollier WER ( 2002) IL-6 promoter polymorphism at position-174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. Clin Exp Rheumatol 20:179–184
27.
Zurück zum Zitat Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376 Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376
28.
Zurück zum Zitat Youinou P, Le Corre R (1999) The multi-faceted role of transforming growth factor-beta in systemic lupus erythematosus. Lupus 8:87–88CrossRefPubMed Youinou P, Le Corre R (1999) The multi-faceted role of transforming growth factor-beta in systemic lupus erythematosus. Lupus 8:87–88CrossRefPubMed
Metadaten
Titel
HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus
verfasst von
Antoni Hrycek
Urszula Siekiera
Paweł Cieślik
Witold Szkróbka
Publikationsdatum
01.11.2005
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 1/2005
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0503-8

Weitere Artikel der Ausgabe 1/2005

Rheumatology International 1/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.